2-(Piperidin-4-yl)acetamide

Catalog No.: 
ACWVGK358
CAS No.: 
184044-10-8
Molecular Formula: 
C7H14N2O
Molecular Weight: 
142.20
2-(Piperidin-4-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$290.00InquiryInquiry
1g95%$754.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Piperidin-4-yl)acetamide
IUPAC Name2-(piperidin-4-yl)acetamide
MDL No.MFCD09055362
Molecular FormulaC7H14N2O
Molecular Weight142.20
SMILESO=C(N)CC1CCNCC1
InChI KeyNWVSHHSCDXUYRS-UHFFFAOYSA-N
Synonym4-Piperidineacetamidehydrochloride;2-(4-piperidinyl)acetamide;2-(4-Piperidyl)acetamide;2-piperidin-4-ylacetamide(SALTDATA: 1.6HCl 0.09C4H8O2);4-Piperidineaetamide HCl;4-Piperidineacetamide HCl;4-Piperidineacetamide
CAS No.184044-10-8

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWVGK358 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBYVD485 route compound structure diagram
    ACBYVD485782493-57-6In Stock
  2. Then
  3. ACWVGK358 route product structure diagram
    ACWVGK358184044-10-8
Inquiry

2. ACWVGK358 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIVOW340 route compound structure diagram
    ACIVOW34059184-90-6In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACWVGK358 route product structure diagram
    ACWVGK358184044-10-8
Inquiry

3. ACWVGK358 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWVGK358 route product structure diagram
    ACWVGK358184044-10-8
Inquiry

Comments (0)